Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bridging Study of C11 PiB and F18 Flutemetamol Brain PET
NCT01607476Phase 2Completed
- Sponsor
- Mayo Clinic
- Start
- Jul 2012
- Primary completion
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of flutemetamol, carbon-11 Pittsburgh compound B in Alzheimer's disease (AD), sponsored by Mayo Clinic. Started Jul 2012; status: completed.
02
Drugs
flutemetamolcarbon-11 Pittsburgh compound B
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT01607476.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01607476.